Evidence map›Paper›PMID 34886862›Full record

ArticleBMC medicine2021

Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort.

Mathilde His, Vivian Viallon, Laure Dossus, Julie A Schmidt, Ruth C Travis, Marc J Gunter, Kim Overvad, Cecilie Kyrø, Anne Tjønneland, Lucie Lécuyer and 26 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Observational
  2. Article
  3. Metabolic profile of biodiverse diets in a healthy European cohort.The American journal of clinical nutrition · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Comprehensive metabolomic characterization of atrial fibrillation.Frontiers in cardiovascular medicine · 2022
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 10 countries.

Mathilde HisInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Vivian ViallonInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Laure DossusInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Julie A SchmidtCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Ruth C TravisCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Marc J GunterInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Kim OvervadDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Cecilie KyrøDanish Cancer Society Research Center, Copenhagen, Denmark.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Lucie LécuyerUniversité Paris-Saclay, UVSQ, Inserm, CESP U1018, "Exposome and Heredity" team, Gustave Roussy, Villejuif, France.
Joseph A RothwellUniversité Paris-Saclay, UVSQ, Inserm, CESP U1018, "Exposome and Heredity" team, Gustave Roussy, Villejuif, France.
Gianluca SeveriUniversité Paris-Saclay, UVSQ, Inserm, CESP U1018, "Exposome and Heredity" team, Gustave Roussy, Villejuif, France.
Theron JohnsonDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Verena KatzkeDepartment of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.
Giovanna MasalaInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Instituto Nazionale dei Tumori di Milano, Milan, Italy.
Salvatore PanicoDipartimento Di Medicina Clinica E Chirurgia, Federico Ii University, Naples, Italy.
Rosario TuminoCancer Registry and Histopathology Department, Provincial Health Authority (ASP 7) Ragusa, Ragusa, Italy.
Alessandra MacciottaDepartment of Clinical and Biological Sciences, University of Turin, Turin, Italy.
Jolanda M A BoerCenter for Nutrition, Prevention, and Health Services, National Institute for Public Health and the Environment (RIVM), Bilthoven, 3720, BA, the Netherlands.
Evelyn M MonninkhofJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Karina Standahl OlsenDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, NO-9037, Tromsø, Norway.
Therese H NøstDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, NO-9037, Tromsø, Norway.
Torkjel M SandangerDepartment of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, NO-9037, Tromsø, Norway.
Antonio AgudoUnit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, L'Hospitalet de Llobregat, Spain.
Maria-Jose SánchezEscuela Andaluza de Salud Pública (EASP), Granada, Spain.
Pilar AmianoMinistry of Health of the Basque Government, Sub-Directorate for Public Health and Addictions of Gipuzkoa, San Sebastián, Spain.
Sandra M Colorado-YoharCIBER Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Eva ArdanazCIBER Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Linda VidmanDepartment of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Anna WinkvistSustainable Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Alicia K HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Elisabete WeiderpassInternational Agency for Research on Cancer (IARC/WHO), Office of the Director, Lyon, France.
Inge HuybrechtsInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France.
Sabina RinaldiInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, 150 cours Albert Thomas, 69372, CEDEX 08, Lyon, France. rinaldis@iarc.fr.
Centre International de Recherche sur le Cancer · FRUiT The Arctic University of Norway · NODanish Cancer Society · DKHeidelberg University · DEInserm · FRUmeå University · SEUniversity of Oxford · GBAarhus University · DKAgenzia Regionale Sanitaria della Puglia · ITAjuntament de L’Hospitalet · ESBiogipuzkoa Health Research Institute · ESCentre de recherche en Epidémiologie et Santé des Populations · FRCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEImperial College London · GBInstituto de Salud Carlos III · ESIstituto per lo Studio e la Prevenzione Oncologica · ITNational Institute for Public Health and the Environment · NL

Funding

Cancer Research UK 14136Cancer Research UK 14136; C8221/A29017Medical Research Council 1000143; MR/N003284/1; MC-UU_12015/1;MC_UU_00006/1; MR/M012190/1Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

backgroundMetabolomics is a promising molecular tool for identifying novel etiological pathways leading to cancer. In an earlier prospective study among pre- and postmenopausal women not using exogenous hormones, we observed a higher risk of breast cancer associated with higher blood concentrations of one metabolite (acetylcarnitine) and a lower risk associated with higher blood concentrations of seven others (arginine, asparagine, phosphatidylcholines (PCs) aa C36:3, ae C34:2, ae C36:2, ae C36:3, and ae C38:2).

methodsTo identify determinants of these breast cancer-related metabolites, we conducted a cross-sectional analysis to identify their lifestyle and anthropometric correlates in 2358 women, who were previously included as controls in case-control studies nested within the European Prospective Investigation into Cancer and Nutrition cohort and not using exogenous hormones at blood collection. Associations of each metabolite concentration with 42 variables were assessed using linear regression models in a discovery set of 1572 participants. Significant associations were evaluated in a validation set (n = 786).

resultsFor the metabolites previously associated with a lower risk of breast cancer, concentrations of PCs ae C34:2, C36:2, C36:3, and C38:2 were negatively associated with adiposity and positively associated with total and saturated fat intakes. PC ae C36:2 was also negatively associated with alcohol consumption and positively associated with two scores reflecting adherence to a healthy lifestyle. Asparagine concentration was negatively associated with adiposity. Arginine and PC aa C36:3 concentrations were not associated to any of the factors examined. For the metabolite previously associated with a higher risk of breast cancer, acetylcarnitine, a positive association with age was observed.

conclusionsThese associations may indicate possible mechanisms underlying associations between lifestyle and anthropometric factors, and risk of breast cancer. Further research is needed to identify potential non-lifestyle correlates of the metabolites investigated.

Indexed as

Breast NeoplasmsCohort StudiesCross-Sectional StudiesFemaleHumansLife StyleProspective StudiesRisk FactorsAnthropometryBreast cancerCross-sectionalLifestyleMetabolites

Identifiers

PMID34886862
PMCPMC8662901
OpenAlexW4200112058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.